<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03857971</url>
  </required_header>
  <id_info>
    <org_study_id>NL67426.091.18</org_study_id>
    <nct_id>NCT03857971</nct_id>
  </id_info>
  <brief_title>Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions</brief_title>
  <acronym>PECTUS-obs</acronym>
  <official_title>Identification of Risk Factors for Acute Coronary Events by Optical Coherence Tomography After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions The 'PECTUS-obs' Trial (Observational Cohort)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare the clinical outcome of Non-ST-elevation myocardial
      infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI) patients with
      non-obstructive, non-culprit coronary lesions and either presence or absence of vulnerable
      plaque characteristics as assessed by optical coherence tomography (OCT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite major advances in the treatment of acute coronary syndromes a large proportion of
      patients is still at risk for new coronary events after experiencing an acute coronary
      syndrome (ACS). Detection of residual vulnerable plaques after ACS using OCT potentially
      identifies patients at high risk for new coronary events. However, no prospectively collected
      data on the prognostic power of OCT for plaque rupture are available at this moment. To
      design trials aimed to reduce events in patients with vulnerable plaques it is required to
      collect such prospective data on the relation between OCT derived characteristics of
      vulnerability and clinical outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 14, 2018</start_date>
  <completion_date type="Anticipated">June 14, 2025</completion_date>
  <primary_completion_date type="Anticipated">June 14, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiac Events</measure>
    <time_frame>2 years</time_frame>
    <description>Composite of all cause mortality, non-fatal myocardial infarction or unplanned revascularization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events</measure>
    <time_frame>1 year</time_frame>
    <description>Composite of all cause mortality, non-fatal myocardial infarction or unplanned revascularization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events</measure>
    <time_frame>5 years</time_frame>
    <description>Composite of all cause mortality, non-fatal myocardial infarction or unplanned revascularization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion Failure</measure>
    <time_frame>2 and 5 years</time_frame>
    <description>Cardiac death caused by target lesion, myocardial infarction caused by target lesion, revascularisation of target lesion</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">438</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Coronary OCT imaging of non flow-limiting lesion</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Coronary OCT imaging will be performed of fractional flow reserve (FFR) negative lesions to assess plaque morphology.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coronary Optical Coherence tomography</intervention_name>
    <description>Optical coherence tomography imaging is performed of non-obstructive, non-culprit coronary lesions to assess plaque morphology.</description>
    <arm_group_label>Coronary OCT imaging of non flow-limiting lesion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent must be obtained.

          -  Patients with STEMI or NSTEMI and residual, non-culprit CAD, with the possibility of
             plaque vulnerability.

          -  Residual plaque(s) is(are) non-obstructive (FFR≥0.80).

        Exclusion Criteria:

          -  Refusal or inability to provide informed consent.

          -  &lt; 18 years of age

          -  Hemodynamic instability, respiratory failure, Kilip class ≥ 3.

          -  Previous Coronary Artery Bypass Grafting (CABG).

          -  Indication for revascularization by CABG.

          -  Anatomy or lesions unsuitable for OCT catheter crossing or imaging (aorta-ostial
             lesions, small diameter segment, severe calcifications, lesion is too distal for OCT
             catheter)

          -  Pregnancy.

          -  Estimated life expectancy &lt; 3 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niels van Royen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan-Quinten H Mol, MD</last_name>
    <phone>00310243616785</phone>
    <email>jan-quinten.mol@radboudumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radboudumc</name>
      <address>
        <city>Nijmegen</city>
        <state>Zuid-Holland</state>
        <zip>6500HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan-Quinten Mol, MD</last_name>
    </contact>
    <investigator>
      <last_name>Niels van Royen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>February 27, 2019</study_first_submitted>
  <study_first_submitted_qc>February 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2019</study_first_posted>
  <last_update_submitted>March 29, 2019</last_update_submitted>
  <last_update_submitted_qc>March 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vulnerable plaque</keyword>
  <keyword>Optical coherence Tomography</keyword>
  <keyword>OCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

